Volpara's Transformative Partnership with U.S. Defense Health Agency
Volpara Health, a pioneering company in cancer detection technology, has secured a pivotal contract with the U.S. Defense Health Agency (DHA) aimed at revolutionizing mammography services within military health facilities. This partnership is a significant step forward in modernizing breast cancer screening for active-duty members, their families, and retirees, showcasing Volpara's commitment to enhancing healthcare for those who serve our nation.
Improving Breast Cancer Screening with Advanced Technology
The contract, valued at approximately $7.3 million over five years, includes the deployment of Volpara's innovative Patient Hub™, a cutting-edge system designed for mammography reporting, risk assessment, and patient tracking. This technology is set to enhance the screenings performed across the military health system, ensuring that service members receive timely and personalized healthcare.
What is Volpara's Patient Hub™?
The Patient Hub™ integrates vital components of breast health management. By streamlining processes such as scheduling, data collection, risk assessments, and mammogram tracking, healthcare providers can facilitate a more efficient patient experience. This system will automate follow-ups and reminders, greatly minimizing the administrative tasks that often burden medical professionals, allowing them to focus more on patient care.
Commitment to Quality and Security
Teri Thomas, CEO of Volpara, expressed enthusiasm about this collaboration: "Working with the Defense Health Agency is an exceptional opportunity to enhance healthcare services for military personnel." She emphasized the importance of meeting rigorous security standards set by the Department of Defense, which underlines Volpara's dedication to patient safety and data integrity.
Historic Impact on Breast Health Services
This contract not only represents a financial investment but also illustrates Volpara’s mission to transform breast health through technological innovation. The use of their software by the Department of Defense since 1990 highlights the long-standing trust in Volpara’s capabilities, marking this partnership as a continuation of a vital legacy in healthcare advancement.
About Volpara Health
Volpara Health is committed to combating cancer by utilizing AI-driven software that empowers healthcare providers with better tools for cancer risk evaluation and recommendations for tailored care strategies. Their systems are currently employed in over 2,000 facilities worldwide, impacting around 17 million patients and supporting three million cancer risk assessments each year. Volpara’s technology not only aids in understanding dense breast tissue but also ensures optimal imaging techniques, thereby supporting healthcare professionals in delivering high-quality care.
Global Reach and Ongoing Innovation
Headquartered in Wellington, New Zealand, with an office in Seattle, Volpara works with leading healthcare institutions globally. They continue to enhance their solutions, ensuring they remain at the forefront of healthcare technology. The company fosters an environment of continuous learning and improvement to adapt to the evolving needs of breast health management.
Frequently Asked Questions
What is Volpara's Patient Hub™?
Volpara's Patient Hub™ is an advanced system for mammography reporting and patient management designed to enhance breast cancer screening.
What is the value of the contract with the Defense Health Agency?
The contract with the Defense Health Agency is valued at approximately $7.3 million over five years.
What benefits does this contract provide to military health facilities?
This contract will modernize breast cancer screening, improve patient tracking, and streamline workflow for providers.
How does the Patient Hub™ enhance patient care?
The Patient Hub™ automates follow-ups and communications, ensuring timely care and significantly reducing administrative burdens for healthcare providers.
Where is Volpara Health headquartered?
Volpara Health is headquartered in Wellington, New Zealand, with an additional office in Seattle.
